Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Diagnostic Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Lung Neoplasms 4 Prostatic Neoplasms 3 Barrett Esophagus 3 Recurrence 2 Neoplasms 2 Multiple Pulmonary Nodules 2 Melanoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinal Fractures 1 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Phyllodes Tumor 1 Osteoporosis 1 Nevus 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Diseases 1 Liver Cirrhosis 1 Inflammatory Bowel Diseases 1 Hypoxia 1

Interventions

pimonidazole 4 TH 302 4 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 4 fluoroazomycin arabinoside 3 Propofol 3 Injections 3 Radiotherapy 2 pomalidomide 1 fluoromisonidazole 1 fludarabine 1 alovudine 1 Tirapazamine 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Temozolomide 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Oxygen 1 Nitroglycerin 1 Nimorazole 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Ketamine 1 Ipilimumab 1 Hydroxychloroquine 1 Furosemide 1 Ferrosoferric Oxide 1 Exercise 1 Ethiodized Oil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04001023 2019-08-07

OVANOX

Turku University Hospital

Phase NA Unknown

Carcinoma, Ovarian Epithelial, Hypoxia, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡